Concepedia

Concept

radiation medicine imaging

Parents

1.6K

Publications

75K

Citations

6.6K

Authors

1.5K

Institutions

Image-Guided Dose Optimization

2005 - 2011

During the 2005–2011 period, radiation medicine imaging centered on dose-aware practices that balanced patient safety with diagnostic and therapeutic quality. Policy white papers, warnings, and nationwide dose surveys propelled a push toward dose reduction without compromising care, informing imaging and treatment workflows. Imaging-guided radiotherapy emerged as a core paradigm, with emphasis on verification and quality assurance, while rapid advances in detectors and in-beam imaging technologies accelerated translational radiotherapy research. Functional imaging matured as an essential planning and response-assessment tool, with positron emission tomography and single-photon emission computed tomography guiding management in lung and head-and-neck cancers and informing post-therapy outcomes.

• Dose optimization and safety take center stage across radiology and therapy, driven by policy white papers, FDA warnings, and nationwide dose surveys, emphasizing reducing exposure while maintaining diagnostic and therapeutic quality [1], [6], [2], [15].

• Functional imaging is increasingly integrated into treatment planning and response assessment, with FDG-PET/SPECT guiding NSCLC and head-and-neck management and informing post-therapy outcomes [8], [14], [20].

• Imaging-guided radiotherapy and rigorous dose verification become core QA paradigms, featuring gated IMRT validation, three‑dimensional dose verification, and IGRT guidelines that improve accuracy and reproducibility [4], [5], [7], [15].

• Advances in imaging and detector technologies propel radiotherapy research, including in‑beam PET, CdTe cameras, MRT-related imaging, and micro-CT–based image-guided systems for small animals and preclinical models [10], [17], [12], [3], [11], [9].

Imaging-Guided Adaptive Radiotherapy

2012 - 2021